Cafepharma Today

January 31 2025 - AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing
Europe to review safety data for Eisai-Biogen Alzheimer's drug
Novartis posts better-than-expected fourth-quarter sales
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Abbott Sues Johnson & Johnson Over New Simponi Drug
Bloomberg
Wednesday, May 6, 2009 - 7:18am
tags:
Abbott Laboratories, JNJ, Simponi, Janssen Biotech
FDA Calendar Updates: Amylin, Alkermes, Eli Lilly, Cell Therapeutics
Seeking Alpha
Wednesday, May 6, 2009 - 7:16am
tags:
Cell Therapeutics, Eli Lilly, FDA, Alkermes, Amylin
Drug maker Lilly to pay Georgia $6 million.Other states file suits over marketing of anti-psychotic drug
AJC,Georgia
Wednesday, May 6, 2009 - 6:17am
tags:
off-label, antipsychotics, settlements, Georgia, Zyprexa
Roche Wins U.S. Approval for Avastin in Brain Cancer
Bloomberg
Wednesday, May 6, 2009 - 6:15am
tags:
Roche, Avastin, brain cancer
Glaxo Sells U.S. Rights to Wellbutrin XL Drug to Biovail for $510 Million
Bloomberg
Wednesday, May 6, 2009 - 6:14am
tags:
GSK, Biovail, Wellbutrin
Elsevier admits journal error
FT.com
Wednesday, May 6, 2009 - 6:12am
tags:
Elsevier, Merck
Cephalon earnings rise more than 80 percent in first quarter on drug sales, lower expenses
Yahoo/AP
Tuesday, May 5, 2009 - 5:30pm
tags:
Cephalon, earnings
FDA alerts doctors to recently added suicide warnings on anti-seizure drugs
Yahoo/AP
Tuesday, May 5, 2009 - 5:28pm
tags:
FDA, warnings, epilepsy
[video]Mad About Options: Growing with Celgene
Yahoo/TheStreet.com
Tuesday, May 5, 2009 - 4:01pm
tags:
Celgene
Cramer: Buy Eli Lilly
CNBC
Tuesday, May 5, 2009 - 4:00pm
tags:
Eli Lilly
Sanofi-aventis' To-Do List
Motley Fool
Tuesday, May 5, 2009 - 3:57pm
tags:
Sanofi
4-Star Stocks Poised to Pop: Abbott Labs
Motley Fool
Tuesday, May 5, 2009 - 3:56pm
tags:
Abbott Laboratories
Amylin Seeks FDA Approval on Extended Byetta Treatment
WSJ Online
Tuesday, May 5, 2009 - 10:35am
tags:
Amylin, FDA, Byetta, diabetes
Amylin, Alkermes rally on FDA filing
Marketwatch
Tuesday, May 5, 2009 - 10:32am
tags:
Amylin, Alkermes, FDA
Bayer Schering Pharma is starting Phase III studies with an innovative low-dose contraceptive patch
Pharma Live
Tuesday, May 5, 2009 - 9:34am
tags:
contraceptive patch, Bayer
Nycomed hopes for Daxas deal, targets IPO
Reuters
Tuesday, May 5, 2009 - 9:32am
tags:
Daxas, Nycomed, licensing, IPOs
Report: Financial Crisis could reshape biotech
Yahoo/AP
Tuesday, May 5, 2009 - 9:04am
tags:
biotech
Teva Pharmaceutical Industries' 1st-quarter profit triples on generic sales, Barr contribution
Yahoo/AP
Tuesday, May 5, 2009 - 9:01am
tags:
Teva Pharmaceuticals, earnings
FDA Calendar Updates: AstraZeneca, GlaxoSmithKline, Sanofi-Aventis
Seeking Alpha
Tuesday, May 5, 2009 - 9:00am
tags:
GSK, FDA, AstraZeneca, Sanofi
Allergan May Be Forming Handle Or Base
Yahoo/Zacks.com
Tuesday, May 5, 2009 - 6:31am
tags:
Allergan

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Unlocking AI’s Promise in Patient Support Programs
Drug Channels
Right There At the Electrode
In the Pipeline
Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline

Latest Jobs

Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Midland, TX
Midland, Texas, US
Lundbeck
Psychiatry Account Manager - Newport News, VA
Newport News, Virginia, US
Lundbeck
Psychiatry Account Manager - Saint Louis South, MO
Saint Louis, Missouri, US
Lundbeck
Psychiatry Account Manager - Macon, GA
Macon, Georgia, US
Lundbeck
Psychiatry Account Manager - Plano, TX
Plano, Texas, US
Lundbeck
Psychiatry Account Manager - College Station, TX
College Station, Texas, US
Lundbeck
Pharmaceutical Sales Representative- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Manager, Associates Membership Sales
Alexandria, Virginia, United States
Health Industry Distributors Association
Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Jacksonville, Florida
Eli Lilly and Company
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information